Colazal News
Market Report -- Short Stories (SLXP) - MSN Money
Credit Suisse initiates SLXP with a Neutral and a $7 tgt saying they view generic Colazal as an obvious setback and now look to 2008 as a transition year ...
Zacks Bull and Bear of the Day Highlights: Arch Coal, Salix ... - Business Wire (press release)
The company suffered a major setback in December 2007 when the FDA granted approval to three generic versions of lead product Colazal. ...
Zacks Bull and Bear of the Day Highlights: Arch Coal, Salix ... - PR-Inside.com (Pressemitteilung)
The company suffered a major setback in December 2007 when the FDA granted approval to three generic versions of lead product Colazal. ...
BioDelivery's Sirgo joins Salix board - Bizjournals.com
... companies with more than one product on the market, recently said it expects to lose money this year thanks to generic competition for its drug Colazal.
Salix shares fall on profit warning - News & Observer
Salix's biggest seller, an anti-inflammatory, gastrointestinal drug called Colazal, faces competition from cheaper, generic versions this year. ...
Salix expects major decline in sales as generics hit market - News & Observer
Salix won't report annual earnings until March 3, but analysts project that Colazal generated about 47 percent of the company's $262 million in revenue last ...
Shares slip after Salix warns of losses - Bizjournals.com
The announcement came after US regulators approved three companies' applications to sell generic versions of Salix's best-selling treatment, Colazal, ...
Salix Submits New Drug Application To FDA For Granulated Mesalamine - Trading Markets (press release)
The stock fell sharply to a new four-year low Monday on news that the company's key product Colazal, also for ulcerative colitis, faced generic competition ...
Pre-Open Movers 12/31: Delta Petroleum (DPTR) Up On Kerkorian ... - StreetInsider.com (subscription)
... Negative Barron\'s article Salix Pharmaceuticals Ltd. (Nasdaq: SLXP) 8% LOWER; Mylan (NYSE: MYL) gets FDA okay for generic Colazal. ...
Generic competition pummels Salix shares - San Antonio Business Journal
Raleigh-based Salix (Nasdaq: SLXP) announced Friday that it is partnering with Watson Pharmaceuticals to create a generic version of Colazal, ...
Colazal RSS Feed